| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA3 GBP7 DNAH2 EIF2S3B GTPBP10 DHX15 EIF2S3 MLH1 TOR1B ATP12A ATP2A1 ATP2A2 DHX29 DNAH9 DNAH11 | 7.03e-05 | 775 | 121 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 DNAH2 DHX15 MLH1 TOR1B ATP12A ATP2A1 ATP2A2 DHX29 DNAH9 DNAH11 | 7.77e-05 | 441 | 121 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.66e-04 | 18 | 121 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA3 GBP7 DNAH2 EIF2S3B GTPBP10 DHX15 EIF2S3 MLH1 TOR1B ATP12A ATP2A1 ATP2A2 DHX29 DNAH9 DNAH11 | 1.69e-04 | 839 | 121 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA3 GBP7 DNAH2 EIF2S3B GTPBP10 DHX15 EIF2S3 MLH1 TOR1B ATP12A ATP2A1 ATP2A2 DHX29 DNAH9 DNAH11 | 1.71e-04 | 840 | 121 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA3 GBP7 DNAH2 EIF2S3B GTPBP10 DHX15 EIF2S3 MLH1 TOR1B ATP12A ATP2A1 ATP2A2 DHX29 DNAH9 DNAH11 | 1.71e-04 | 840 | 121 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | tRNA binding | 1.87e-04 | 87 | 121 | 5 | GO:0000049 | |
| GeneOntologyMolecularFunction | alanine-tRNA ligase activity | 2.17e-04 | 4 | 121 | 2 | GO:0004813 | |
| GeneOntologyMolecularFunction | glycerophosphodiester phosphodiesterase activity | 5.38e-04 | 6 | 121 | 2 | GO:0008889 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.37e-04 | 28 | 121 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | transporter activity | GABRP ABCA3 SLC37A3 GRIK1 ATG2A PKD1L3 CHRNE SLC52A3 SLC6A4 CNNM3 SLCO1C1 KCND2 SLC22A3 LRRC8A SV2C ATP12A ATP2A1 ATP2A2 | 7.54e-04 | 1289 | 121 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRP ABCA3 SLC37A3 GRIK1 PKD1L3 CHRNE SLC52A3 SLC6A4 CNNM3 SLCO1C1 KCND2 SLC22A3 LRRC8A SV2C ATP12A ATP2A1 ATP2A2 | 7.58e-04 | 1180 | 121 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | XMP 5'-nucleosidase activity | 9.96e-04 | 8 | 121 | 2 | GO:0106411 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | DAGLB EPHX2 MBLAC2 NT5C3A PON1 NT5C3B PTBP1 AARSD1 GDE1 AARS2 PTPRJ XRN1 GPCPD1 | 1.23e-03 | 807 | 121 | 13 | GO:0016788 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 DNAH2 DHX15 MLH1 TOR1B ATP12A ATP2A1 ATP2A2 DHX29 DNAH9 DNAH11 | 1.28e-03 | 614 | 121 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.34e-03 | 36 | 121 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.34e-03 | 36 | 121 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.45e-03 | 37 | 121 | 3 | GO:0045505 | |
| Domain | - | 8.05e-06 | 74 | 120 | 6 | 3.40.50.410 | |
| Domain | HAD-like_dom | 1.18e-05 | 79 | 120 | 6 | IPR023214 | |
| Domain | DHC_N1 | 1.41e-05 | 8 | 120 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.41e-05 | 8 | 120 | 3 | IPR013594 | |
| Domain | UMPH-1 | 4.09e-05 | 2 | 120 | 2 | PF05822 | |
| Domain | Pyrimidine_nucleotidase_eu | 4.09e-05 | 2 | 120 | 2 | IPR006434 | |
| Domain | VWF_A | 4.27e-05 | 99 | 120 | 6 | IPR002035 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.94e-05 | 14 | 120 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 8.94e-05 | 14 | 120 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.94e-05 | 14 | 120 | 3 | IPR013602 | |
| Domain | DHC_N2 | 8.94e-05 | 14 | 120 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 8.94e-05 | 14 | 120 | 3 | IPR011704 | |
| Domain | MT | 8.94e-05 | 14 | 120 | 3 | PF12777 | |
| Domain | AAA_8 | 8.94e-05 | 14 | 120 | 3 | PF12780 | |
| Domain | AAA_5 | 8.94e-05 | 14 | 120 | 3 | PF07728 | |
| Domain | DHC_fam | 1.11e-04 | 15 | 120 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.11e-04 | 15 | 120 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.11e-04 | 15 | 120 | 3 | IPR004273 | |
| Domain | Ala-tRNA-lgiase_IIc | 1.22e-04 | 3 | 120 | 2 | IPR002318 | |
| Domain | P-type_ATPase_IIA | 1.22e-04 | 3 | 120 | 2 | IPR005782 | |
| Domain | ATPase_P-typ_TM_dom | 1.36e-04 | 16 | 120 | 3 | IPR023298 | |
| Domain | - | 1.36e-04 | 16 | 120 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.65e-04 | 17 | 120 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.65e-04 | 17 | 120 | 3 | PF00689 | |
| Domain | VWFA | 1.85e-04 | 82 | 120 | 5 | PS50234 | |
| Domain | Cation_ATPase_N | 1.97e-04 | 18 | 120 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 1.97e-04 | 18 | 120 | 3 | SM00831 | |
| Domain | VWA | 2.07e-04 | 84 | 120 | 5 | SM00327 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.32e-04 | 19 | 120 | 3 | IPR004014 | |
| Domain | Ala-tRNA-synth_IIc_core | 2.44e-04 | 4 | 120 | 2 | IPR018165 | |
| Domain | Ala-tRNA-synth_IIc_N | 2.44e-04 | 4 | 120 | 2 | IPR018164 | |
| Domain | tRNA-synt_2c | 2.44e-04 | 4 | 120 | 2 | PF01411 | |
| Domain | AA_TRNA_LIGASE_II_ALA | 2.44e-04 | 4 | 120 | 2 | PS50860 | |
| Domain | AAA | 3.36e-04 | 144 | 120 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 3.36e-04 | 144 | 120 | 6 | IPR003593 | |
| Domain | HnRNP-L/PTB | 4.04e-04 | 5 | 120 | 2 | IPR006536 | |
| Domain | GP_PDE_dom | 8.42e-04 | 7 | 120 | 2 | IPR030395 | |
| Domain | tRNA_SAD | 8.42e-04 | 7 | 120 | 2 | IPR012947 | |
| Domain | GlyceroP-diester-Pdiesterase | 8.42e-04 | 7 | 120 | 2 | IPR004129 | |
| Domain | GDPD | 8.42e-04 | 7 | 120 | 2 | PF03009 | |
| Domain | tRNA_SAD | 8.42e-04 | 7 | 120 | 2 | SM00863 | |
| Domain | GP_PDE | 8.42e-04 | 7 | 120 | 2 | PS51704 | |
| Domain | tRNA_SAD | 8.42e-04 | 7 | 120 | 2 | PF07973 | |
| Domain | Thr/Ala-tRNA-synth_IIc_edit | 1.12e-03 | 8 | 120 | 2 | IPR018163 | |
| Domain | Epox_hydrolase-like | 1.12e-03 | 8 | 120 | 2 | IPR000639 | |
| Domain | - | 1.12e-03 | 32 | 120 | 3 | 3.40.1110.10 | |
| Domain | - | 1.12e-03 | 32 | 120 | 3 | 2.70.150.10 | |
| Domain | Calx_beta | 1.43e-03 | 9 | 120 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.43e-03 | 9 | 120 | 2 | PF03160 | |
| Domain | ATPase_P-typ_cyto_domN | 1.46e-03 | 35 | 120 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.58e-03 | 36 | 120 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.58e-03 | 36 | 120 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.58e-03 | 36 | 120 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.71e-03 | 37 | 120 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.71e-03 | 37 | 120 | 3 | PF00122 | |
| Domain | Hydrolase_3 | 1.78e-03 | 10 | 120 | 2 | PF08282 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.02e-05 | 27 | 95 | 4 | M47755 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 3.44e-05 | 10 | 95 | 3 | MM1469 | |
| Pubmed | 1.37e-06 | 152 | 125 | 7 | 34299191 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 31178125 | ||
| Pubmed | FAT4 NUP210L CAMK4 DNAH2 PFAS EIF2S3B PTBP1 SORCS1 DHX15 EIF2S3 SV2C PLOD1 VSIG10L2 | 3.48e-06 | 754 | 125 | 13 | 35906200 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12556521 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32209671 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19644701 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 1.28e-05 | 2 | 125 | 2 | 14638697 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12584728 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34910522 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21768390 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29790931 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15718407 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11402072 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32276354 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12213192 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27681424 | ||
| Pubmed | Glycogen synthase kinase-3β is involved in C-reactive protein-induced endothelial cell activation. | 1.28e-05 | 2 | 125 | 2 | 24228880 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11687802 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19033200 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. | 1.28e-05 | 2 | 125 | 2 | 10603953 | |
| Pubmed | Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight. | 1.28e-05 | 2 | 125 | 2 | 34769190 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18953100 | ||
| Pubmed | SERCA overexpression reduces hydroxyl radical injury in murine myocardium. | 1.28e-05 | 2 | 125 | 2 | 16798816 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17606642 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21068324 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12975374 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 1.28e-05 | 2 | 125 | 2 | 16325480 | |
| Pubmed | 2.45e-05 | 16 | 125 | 3 | 16880404 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 FKBP9 EXTL3 GDE1 DHX15 MEST CNNM3 COCH PTPRJ SLC22A3 LRRC8A TOR1B PLOD1 ATP2A2 PCDH7 | 2.83e-05 | 1201 | 125 | 15 | 35696571 |
| Pubmed | 3.54e-05 | 250 | 125 | 7 | 33536335 | ||
| Pubmed | RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3. | 3.84e-05 | 3 | 125 | 2 | 30468920 | |
| Pubmed | The role of phospholamban and GSK3 in regulating rodent cardiac SERCA function. | 3.84e-05 | 3 | 125 | 2 | 32755452 | |
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 3.84e-05 | 3 | 125 | 2 | 30801007 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 32311818 | ||
| Pubmed | Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle. | 3.84e-05 | 3 | 125 | 2 | 27055500 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 25615793 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 12667457 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 15972723 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 16754798 | ||
| Pubmed | BVVL/ FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes. | 3.84e-05 | 3 | 125 | 2 | 33189404 | |
| Pubmed | MRG15 is required for pre-mRNA splicing and spermatogenesis. | 3.84e-05 | 3 | 125 | 2 | 27573846 | |
| Pubmed | Molecular basis of titin exon exclusion by RBM20 and the novel titin splice regulator PTB4. | 3.84e-05 | 3 | 125 | 2 | 29518215 | |
| Pubmed | Expression of human nPTB is limited by extreme suboptimal codon content. | 3.84e-05 | 3 | 125 | 2 | 18335065 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 11526231 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 16410239 | ||
| Pubmed | Identification of Drosophila and human 7-methyl GMP-specific nucleotidases. | 3.84e-05 | 3 | 125 | 2 | 23223233 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 27791185 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 17329592 | ||
| Pubmed | Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart. | 3.84e-05 | 3 | 125 | 2 | 9038922 | |
| Pubmed | PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells. | 3.84e-05 | 3 | 125 | 2 | 26416554 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 22466636 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SLC37A3 HECTD4 PFAS EXTL3 ATG2A SLC52A3 ACTR1A EHBP1L1 RBM19 PDZD8 NUP188 HERC2 DNMBP D2HGDH | 4.56e-05 | 1105 | 125 | 14 | 35748872 |
| Pubmed | 4.94e-05 | 20 | 125 | 3 | 18978355 | ||
| Pubmed | TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. | 5.75e-05 | 21 | 125 | 3 | 20194497 | |
| Pubmed | 5.75e-05 | 21 | 125 | 3 | 23137377 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 16987514 | ||
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 7.65e-05 | 4 | 125 | 2 | 18849963 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 25920809 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 11231079 | ||
| Pubmed | Injury induces early activation of T-cell receptor signaling pathways in CD4+ regulatory T cells. | 7.65e-05 | 4 | 125 | 2 | 20720513 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 25445355 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 9295312 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 25110346 | ||
| Pubmed | Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. | 7.65e-05 | 4 | 125 | 2 | 31836389 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 22232963 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 34548489 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 10555147 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 36140829 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 12032137 | ||
| Pubmed | Ischemic Stroke and Six Genetic Variants in CRP, EPHX2, FGA, and NOTCH3 Genes: A Meta-Analysis. | 7.65e-05 | 4 | 125 | 2 | 27266621 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 18505467 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 7.65e-05 | 4 | 125 | 2 | 10362770 | |
| Pubmed | Glycogen synthase kinase 3beta interaction protein functions as an A-kinase anchoring protein. | 7.65e-05 | 4 | 125 | 2 | 20007971 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 27307045 | ||
| Pubmed | Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. | 7.65e-05 | 4 | 125 | 2 | 12074580 | |
| Pubmed | SERCA1a can functionally substitute for SERCA2a in the heart. | 7.65e-05 | 4 | 125 | 2 | 9887021 | |
| Pubmed | Murine SEC24D can substitute functionally for SEC24C during embryonic development. | 7.65e-05 | 4 | 125 | 2 | 34702932 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 8.30e-05 | 498 | 125 | 9 | 36634849 | |
| Pubmed | TDRKH FAT4 CAMK4 PTBP1 CNNM3 SEC24D RBM19 EIF2S3 PI4KB XRN1 PCDH7 | 1.19e-04 | 777 | 125 | 11 | 35844135 | |
| Pubmed | The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers. | 1.27e-04 | 5 | 125 | 2 | 29358707 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 30299255 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 20530871 | ||
| Pubmed | Polypyrimidine tract-binding proteins are essential for B cell development. | 1.27e-04 | 5 | 125 | 2 | 32081131 | |
| Pubmed | The hnRNP and cytoskeletal protein raver1 contributes to synaptic plasticity. | 1.27e-04 | 5 | 125 | 2 | 18061163 | |
| Pubmed | PTBP1 is required for embryonic development before gastrulation. | 1.27e-04 | 5 | 125 | 2 | 21423341 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 22249249 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 26909801 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 16787706 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 12581738 | ||
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 24920589 | ||
| Pubmed | An Integrative Synthetic Biology Approach to Interrogating Cellular Ubiquitin and Ufm Signaling. | 1.39e-04 | 28 | 125 | 3 | 32545848 | |
| Pubmed | 1.55e-04 | 29 | 125 | 3 | 15071553 | ||
| Pubmed | Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes. | 1.90e-04 | 6 | 125 | 2 | 20056567 | |
| Pubmed | PTBP1 and PTBP2 Serve Both Specific and Redundant Functions in Neuronal Pre-mRNA Splicing. | 1.90e-04 | 6 | 125 | 2 | 27926877 | |
| Pubmed | PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. | 1.90e-04 | 6 | 125 | 2 | 22246437 | |
| Pubmed | Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of Tau protein in vitro. | 1.90e-04 | 6 | 125 | 2 | 9353289 | |
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 12597860 | ||
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 24700879 | ||
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 33347437 | ||
| Pubmed | 1.90e-04 | 6 | 125 | 2 | 7566346 | ||
| Cytoband | 7p11.1 | 7.35e-06 | 2 | 125 | 2 | 7p11.1 | |
| GeneFamily | Dyneins, axonemal | 5.22e-05 | 17 | 79 | 3 | 536 | |
| GeneFamily | ATPases Ca2+ transporting | 6.65e-04 | 9 | 79 | 2 | 1209 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 7.59e-04 | 41 | 79 | 3 | 1298 | |
| GeneFamily | DEAH-box helicases | 2.17e-03 | 16 | 79 | 2 | 500 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 5.48e-06 | 200 | 125 | 8 | M6208 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-08 | 184 | 125 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-08 | 184 | 125 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-08 | 184 | 125 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 160 | 125 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 160 | 125 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | severe-CD4+_T_naive|World / disease stage, cell group and cell class | 5.46e-06 | 157 | 125 | 6 | ccf9abe0b59e9ea728cec4bba1872ffe14c7385c | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.88e-06 | 159 | 125 | 6 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-06 | 160 | 125 | 6 | 028b5261a1da832d52f66fb620db83e5fbbd874a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-06 | 160 | 125 | 6 | 1f4ee446436726c3d373f56d87dd80b6a12e8b9e | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.54e-06 | 162 | 125 | 6 | aed15eef32419b8a4e2afdb9776c2bf2802e96f1 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 7.78e-06 | 167 | 125 | 6 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-06 | 169 | 125 | 6 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-06 | 169 | 125 | 6 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.23e-05 | 181 | 125 | 6 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.53e-05 | 188 | 125 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-05 | 193 | 125 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-05 | 198 | 125 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-05 | 198 | 125 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 118 | 125 | 5 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-05 | 118 | 125 | 5 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.10e-05 | 199 | 125 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 199 | 125 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 135 | 125 | 5 | 7b456fa9a5f5ce58976a8f1fad18c0f96a096930 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.40e-05 | 144 | 125 | 5 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.15e-05 | 161 | 125 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.15e-05 | 161 | 125 | 5 | c4970501c038ed36de447da70eabff020ad78713 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.15e-05 | 161 | 125 | 5 | 41a89a3d99a9bd6039a3d881d1d9dcd18bc07f25 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.98e-05 | 164 | 125 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 167 | 125 | 5 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.09e-04 | 167 | 125 | 5 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 168 | 125 | 5 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 168 | 125 | 5 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.28e-04 | 173 | 125 | 5 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.32e-04 | 174 | 125 | 5 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 175 | 125 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 175 | 125 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 93 | 125 | 4 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 93 | 125 | 4 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 93 | 125 | 4 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 176 | 125 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-04 | 177 | 125 | 5 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-04 | 177 | 125 | 5 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 178 | 125 | 5 | 829ea00c022a78d1861aa3ec53503272976775d9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.46e-04 | 178 | 125 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 1.46e-04 | 178 | 125 | 5 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-04 | 178 | 125 | 5 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 180 | 125 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 181 | 125 | 5 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | Club-club-8|World / Class top | 1.62e-04 | 182 | 125 | 5 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-04 | 182 | 125 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.67e-04 | 183 | 125 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 185 | 125 | 5 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 8fc0487fc1b2fd403bd7c257fcabbff652f971c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | e4f1259725160719e5fd13d76e5a707efed70013 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-04 | 187 | 125 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 187 | 125 | 5 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 188 | 125 | 5 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.94e-04 | 189 | 125 | 5 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 189 | 125 | 5 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.94e-04 | 189 | 125 | 5 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-04 | 190 | 125 | 5 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 190 | 125 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 190 | 125 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.98e-04 | 190 | 125 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 190 | 125 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 103 | 125 | 4 | 3a0f02ce52c4e2eda5b987c89317280c08f90cb3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 191 | 125 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 191 | 125 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 191 | 125 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-04 | 192 | 125 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.13e-04 | 193 | 125 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.18e-04 | 194 | 125 | 5 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.18e-04 | 194 | 125 | 5 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-04 | 194 | 125 | 5 | e90f6717e3421f8978d1fc1b2f30dcf69f6fcce7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 195 | 125 | 5 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 125 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-04 | 195 | 125 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-04 | 195 | 125 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 195 | 125 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 125 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 125 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 125 | 5 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 196 | 125 | 5 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-04 | 196 | 125 | 5 | 072e0e29be4639344ead4ea6ad521e3338f5f8af | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 196 | 125 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 196 | 125 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 125 | 5 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|hematopoetic_progenitors / Lineage and Cell class | 2.34e-04 | 197 | 125 | 5 | 6172a1b98ff840d9174b1ab20ba0c202a7ef87af | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 197 | 125 | 5 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| Drug | 1i32 | 4.49e-07 | 129 | 121 | 8 | CID000446186 | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; HL60; HT_HG-U133A | 1.26e-06 | 200 | 121 | 9 | 2722_UP | |
| Drug | magnesium | NT5C3A LDHAL6B NT5C3B GRIK1 ADGRV1 GTPBP10 GSK3B YARS2 ACTR1A CNNM3 MAPK12 AARS2 KCND2 EIF2S3 MLH1 PRKAR2B ATP12A ATP2A1 ATP2A2 DNAH9 DNAH11 | 6.25e-06 | 1325 | 121 | 21 | CID000000888 |
| Disease | Congestive heart failure | 4.11e-07 | 110 | 123 | 7 | C0018802 | |
| Disease | Heart failure | 4.11e-07 | 110 | 123 | 7 | C0018801 | |
| Disease | Left-Sided Heart Failure | 4.11e-07 | 110 | 123 | 7 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 4.11e-07 | 110 | 123 | 7 | C0235527 | |
| Disease | Heart Decompensation | 4.11e-07 | 110 | 123 | 7 | C1961112 | |
| Disease | Myocardial Failure | 4.11e-07 | 110 | 123 | 7 | C1959583 | |
| Disease | myocardial infarction | TDRKH HECTD4 PKD1L3 SLC6A4 SEC24D EHBP1L1 DNMBP ARHGEF26 ATP2A2 | 1.69e-05 | 350 | 123 | 9 | EFO_0000612 |
| Disease | MEHMO syndrome (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.72e-05 | 2 | 123 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Brody myopathy (implicated_via_orthology) | 5.16e-05 | 3 | 123 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Fraser syndrome (implicated_via_orthology) | 1.03e-04 | 4 | 123 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | retinal vein occlusion (is_marker_for) | 1.03e-04 | 4 | 123 | 2 | DOID:1727 (is_marker_for) | |
| Disease | heart disease (is_implicated_in) | 1.71e-04 | 5 | 123 | 2 | DOID:114 (is_implicated_in) | |
| Disease | respiratory failure, COVID-19 | 2.39e-04 | 29 | 123 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | bipolar disorder (is_implicated_in) | 2.39e-04 | 29 | 123 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | hypopituitarism (implicated_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | MEDULLOBLASTOMA | 2.56e-04 | 6 | 123 | 2 | 155255 | |
| Disease | Myocarditis | 2.56e-04 | 6 | 123 | 2 | C0027059 | |
| Disease | Carditis | 2.56e-04 | 6 | 123 | 2 | C0869523 | |
| Disease | heavy drinking | 2.56e-04 | 6 | 123 | 2 | C0687132 | |
| Disease | Medulloblastoma | 2.56e-04 | 6 | 123 | 2 | cv:C0025149 | |
| Disease | esophageal carcinoma | 2.64e-04 | 30 | 123 | 3 | EFO_0002916 | |
| Disease | Alcoholic Intoxication | 3.21e-04 | 32 | 123 | 3 | C0001969 | |
| Disease | heart disease (implicated_via_orthology) | 5.36e-04 | 38 | 123 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | leukodystrophy (implicated_via_orthology) | 6.09e-04 | 9 | 123 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Glioma | 6.09e-04 | 9 | 123 | 2 | cv:C0017638 | |
| Disease | X-21467 measurement | 6.09e-04 | 9 | 123 | 2 | EFO_0020007 | |
| Disease | Melancholia | 6.71e-04 | 41 | 123 | 3 | C0025193 | |
| Disease | Depression, Neurotic | 6.71e-04 | 41 | 123 | 3 | C0282126 | |
| Disease | Depressive Syndrome | 7.21e-04 | 42 | 123 | 3 | C0086133 | |
| Disease | Metabolic Diseases | 7.59e-04 | 10 | 123 | 2 | C0025517 | |
| Disease | medulloblastoma (is_implicated_in) | 7.59e-04 | 10 | 123 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | otitis media (is_marker_for) | 7.59e-04 | 10 | 123 | 2 | DOID:10754 (is_marker_for) | |
| Disease | Unipolar Depression | 7.79e-04 | 259 | 123 | 6 | C0041696 | |
| Disease | Diabetic Retinopathy | 9.25e-04 | 11 | 123 | 2 | C0011884 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 9.25e-04 | 11 | 123 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | Heart Diseases | 9.41e-04 | 46 | 123 | 3 | C0018799 | |
| Disease | Endogenous depression | 9.41e-04 | 46 | 123 | 3 | C0011573 | |
| Disease | calcium measurement | DNAH2 CHRNE HINFP CNNM3 EHBP1L1 SLC22A3 GPCPD1 PRKAR2B ATP2A2 | 1.30e-03 | 628 | 123 | 9 | EFO_0004838 |
| Disease | Depressed mood | 1.30e-03 | 13 | 123 | 2 | C0344315 | |
| Disease | response to TNF antagonist | 1.50e-03 | 54 | 123 | 3 | EFO_0004653 | |
| Disease | Hamman-Rich syndrome | 1.52e-03 | 14 | 123 | 2 | C0085786 | |
| Disease | orotic acid measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0010516 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 1.52e-03 | 14 | 123 | 2 | DOID:10873 (is_marker_for) | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.67e-03 | 56 | 123 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | fibrinogen measurement, factor VII measurement | 1.85e-03 | 58 | 123 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.99e-03 | 16 | 123 | 2 | C0745103 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 2.25e-03 | 17 | 123 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | metabolite measurement | 2.45e-03 | 560 | 123 | 8 | EFO_0004725 | |
| Disease | essential hypertension (is_implicated_in) | 2.52e-03 | 18 | 123 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Coronary Arteriosclerosis | 2.56e-03 | 65 | 123 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 2.56e-03 | 65 | 123 | 3 | C1956346 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.81e-03 | 19 | 123 | 2 | C1333991 | |
| Disease | susceptibility to mononucleosis measurement | 3.03e-03 | 69 | 123 | 3 | EFO_0008403 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.23e-03 | 145 | 123 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Metabolic Syndrome X | 3.44e-03 | 21 | 123 | 2 | C0524620 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.44e-03 | 21 | 123 | 2 | C1800706 | |
| Disease | serum albumin measurement | 3.44e-03 | 592 | 123 | 8 | EFO_0004535 | |
| Disease | serum alanine aminotransferase measurement | DAGLB HLA-DPA1 HECTD4 DNAH2 PTBP1 SLC6A4 PTPRJ MLH1 TOR1B DNMBP | 3.51e-03 | 869 | 123 | 10 | EFO_0004735 |
| Disease | Major Depressive Disorder | 3.57e-03 | 243 | 123 | 5 | C1269683 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIPVFIFSAGIGDVL | 196 | Q9H0P0 | |
| PLFIFSAGIGDILEE | 151 | Q969T7 | |
| GLTIFPEELIIGRTI | 306 | P08319 | |
| VLRIGGIFETVENEP | 36 | P39086 | |
| ELTIILQGLDGPVFT | 1616 | Q6V0I7 | |
| FVPIIGFLILEEGET | 2886 | Q8WXG9 | |
| GELVTEGVAESLFLP | 156 | P20036 | |
| VTDDIPVFLGLVGDL | 2106 | Q96DT5 | |
| GIALIGEPAVIFLDE | 1526 | Q99758 | |
| FQVVLEDTVLFPEGG | 41 | Q9BTE6 | |
| SVSEELPLFVGDIIE | 16 | Q6XZF7 | |
| EGFVELLGPLRTVDE | 196 | Q6XZF7 | |
| LLITDFPVEDGGTLL | 46 | Q96DR7 | |
| TSLTIDGVVFVIDPG | 426 | O43143 | |
| GITIPDVVFVIDTGR | 936 | Q7Z478 | |
| GEETITAFVEPFVIL | 81 | O14983 | |
| ELVEGFVGSIEVAVP | 71 | Q2TAZ0 | |
| FLLPEVDRQVGTDGL | 286 | Q8IXJ9 | |
| DFGGIETLRVPSELV | 91 | Q04844 | |
| EEGLILFDQIPVSSG | 5156 | Q9HC84 | |
| VLLPEGGITAIVEFL | 616 | Q9Y4C8 | |
| GGITAIVEFLEPLEA | 621 | Q9Y4C8 | |
| DVFSELSIPLGVEFV | 1141 | Q5T481 | |
| SGIPDTVFDLVELEV | 436 | Q8IWT6 | |
| DIGITDATVTELIPG | 676 | Q12913 | |
| EIDPVEILLDLGFGA | 141 | Q6ZRS4 | |
| EGDFTGVLLPELVVS | 1126 | O95714 | |
| PTEISLVLELVTGGE | 111 | Q16566 | |
| PIGTITILFIDLGTD | 816 | P54707 | |
| AFIVGLLPGLEEGSE | 146 | Q9Y3R5 | |
| FLQPLGGVATAEEEV | 101 | Q5HYC2 | |
| ITGDAFVPGERSVII | 106 | Q6UWP7 | |
| PDGFLEIGNLETIIS | 156 | Q6ZQW0 | |
| LELSPVERGVVSIFG | 116 | P08620 | |
| GEVPGSAVLVFDIEL | 31 | Q75LS8 | |
| GIDEEVFLSIPCILG | 331 | Q9BYZ2 | |
| EGTVFVLAVGVVLSP | 196 | Q7Z3T1 | |
| LFEIDPTSGVVSLVG | 791 | O60245 | |
| IGRLFDGTEPIVLDS | 56 | Q719H9 | |
| EGLSLRDVFLGETVP | 141 | Q8NEN9 | |
| TITLVVSDGEAGPFV | 976 | Q5H8C1 | |
| GSGFPETRTLEIEIL | 591 | Q8N3D4 | |
| DEELAFFGLIPEIIG | 116 | Q9NZV8 | |
| ILDVAGSIFIAALPG | 596 | Q8N8V2 | |
| LELLVTEPGDGGIFT | 351 | Q9BTN0 | |
| EDVSGGLPFLVDLAL | 766 | Q9Y4D8 | |
| GDEALPTVLVGVFIE | 281 | Q02809 | |
| EPGISILEDGTLLVI | 1311 | Q96RW7 | |
| DPFTNELVIFITGGL | 191 | P47890 | |
| VPGSAVLVFDIELLE | 461 | O95302 | |
| GEETITAFVEPFVIL | 81 | P16615 | |
| VELDIEFTSDGIPVL | 96 | Q9NZC3 | |
| TPEEFSILITEVGLG | 91 | A6NGN9 | |
| LPAVFGVLGRTEEAL | 16 | P34913 | |
| PLESEIIIDDGQFGI | 101 | Q9NPB8 | |
| IIPISAVTGEGIEEL | 321 | A4D1E9 | |
| PLIEEEIDGLSGLLF | 261 | Q9UQ03 | |
| ATVVSIIIVFDPLGG | 146 | Q8NCG7 | |
| LFEALEVGAVPVVLG | 451 | O43909 | |
| EFVLNDELPGRIITG | 281 | Q01740 | |
| LEIVGFIDIADISSP | 251 | Q96SY0 | |
| PVDIVFLLDGSERLG | 831 | P12110 | |
| IFPGDSGVDQLVEII | 256 | P49841 | |
| GGSEILFEVPEVTVA | 96 | P02741 | |
| LLFRPDLIGEESEGI | 261 | P61163 | |
| LEVGAEQTEFLRGPL | 1286 | Q5VV63 | |
| DVVIDTGLGLRSLPE | 41 | Q68D91 | |
| LIIFLTDGEPTAGVT | 391 | Q6UXX5 | |
| INLFGEEALPGVLVT | 476 | Q8N6U8 | |
| PAGLTELLQGFTVEV | 6 | P31323 | |
| PEESRVLGFGIVLES | 261 | Q8N7W2 | |
| LGEEISLNPSVGIFI | 1956 | Q9NYC9 | |
| QILGAVGALPEIFTE | 356 | Q2VIR3 | |
| TEVVLTADPVTGFGI | 471 | Q9Y3R0 | |
| IRISDLGLATEIPEG | 326 | P32298 | |
| ESSLQGIILETVPGE | 421 | Q9BQA5 | |
| EFTGLEPIVSDVIRG | 526 | O43405 | |
| PDSTLIAEIILFGEG | 1931 | Q9P225 | |
| IDFFISGVVELPGAL | 381 | O75751 | |
| EIGVFSLGVPVDALF | 271 | Q9Y597 | |
| DSVGVVGSPEIVVLL | 61 | Q5EB52 | |
| VGGSVPVFDEIILST | 136 | Q8N465 | |
| FGGEPVQIALTLDIA | 56 | O00591 | |
| GTAVLEVTSIEPFGV | 1351 | Q5VU65 | |
| DLGPFIVDLITFTEG | 321 | Q14653 | |
| ESLGRNIFLGEVEVP | 356 | Q8IYJ3 | |
| EVPIIFTLLGVGTVT | 71 | Q9NQ40 | |
| GVEVFVVGFVLPSAE | 166 | Q496J9 | |
| GSEDLEILPNGLAFI | 51 | P27169 | |
| LPGEVTETEVIALGL | 66 | Q9UKA9 | |
| FEEFLTVGIDIVPAV | 181 | Q1RMZ1 | |
| GFRDSVPIQGITLEE | 866 | Q14934 | |
| LTGEDVFGITVPLIT | 261 | Q9Y2Z4 | |
| TQVLPFLALGIGVDD | 456 | Q9Y6C5 | |
| EEVFALDPVLGTFLI | 1641 | Q7Z443 | |
| GIITELGVFAPEELR | 336 | Q9BV20 | |
| SLGILIFVLIEGDFP | 11 | Q9BZV3 | |
| FSLEIDEEGNLIGLP | 626 | P40692 | |
| SVITEGVGELSVIDP | 31 | Q9UBF8 | |
| SLPLLVFADVQEGGT | 171 | P35346 | |
| VLETLGPLVGFLGTE | 1321 | Q7RTU9 | |
| IFTEIGTIAAGIPDL | 1656 | Q7RTU9 | |
| FLGSLVPVVVETLGD | 371 | Q5JTZ9 | |
| VTDVGEVFVPLLDGF | 511 | O94855 | |
| LVFLVGEVVPAAVSG | 231 | Q8NE01 | |
| PETELAVIFGESIAL | 261 | Q9NYW3 | |
| DFFLVLLDPVGGDVE | 91 | P98169 | |
| EDVGDERVLLISGFP | 91 | Q9Y2W6 | |
| IVIFFGLLVSPEEIG | 221 | Q8NCC5 | |
| VLSVLFAEEPGLVLE | 941 | O15067 | |
| IPSSLVGVIDGSFEI | 76 | Q9NYB5 | |
| EVSVDFGLQLVGSLP | 16 | Q86TI0 | |
| APEVSEAVSLILGFV | 281 | Q6ZS81 | |
| EVLFDEEFPGGLTIR | 1141 | Q8IZH2 | |
| SVDEILGPLTEILEG | 1176 | Q5SRE5 | |
| FSGEEFGPLTRLVLV | 166 | O75830 | |
| EGLGFTLTVVPEEEI | 101 | Q6UXR4 | |
| VIFGSPLTEEGIAQI | 111 | Q14CB8 | |
| PLFTGETVSLVDVDI | 281 | O14512 | |
| TAGFEPVVIENVLEG | 181 | Q9HD40 | |
| EVLETLGPLVGFLGT | 1321 | A6NGW2 | |
| TPLEVLEDIIGFALA | 1046 | Q6PGP7 | |
| EEGLIATGVRISELP | 1376 | Q9C0G0 | |
| FVDGVLGEPGEETLI | 631 | Q8WY21 | |
| GEALVGVTEPLFQLD | 191 | P0DP72 | |
| AGLEGVITAVLDEFP | 441 | P31645 | |
| LPIDVTEGEVISLGL | 66 | P26599 | |
| VVAAFEPITVGLAIG | 21 | O14657 | |
| QVLGAVGALPEIFTE | 356 | P41091 | |
| VIGLLDVFTPDETLD | 86 | P53778 | |
| AEEETIFAILGPGVA | 111 | Q86VE0 |